Work

Corrigendum to: A phase II evaluation of Pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group Study [Gynecol Oncol 133 (2014) 537–541]

Year: 2014

Type: erratum

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2014.08.011

Authors: Susana M. Campos, William E. Brady, Katherine M. Moxley, Roisin E. O'Cearbhaill, Paula S. Lee, Paul A. DiSilvestro, Jacob Rotmensch, PeterG. Rose, Premal H. Thaker, David M. O'Malley, ParvizHanjani, Rosemary E. Zuna, Martee L. Hensley

Institutions: Dana-Farber Cancer Institute, Roswell Park Comprehensive Cancer Center, University of Oklahoma, Memorial Sloan Kettering Cancer Center, Duke Medical Center, Women & Infants Hospital of Rhode Island, Rush University Medical Center, Cleveland Clinic, Washington University in St. Louis, The Ohio State University, Abington Memorial Hospital

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2023448703

Cites:

Cited by:

Related to: 10